Sunday, March 4, 2012

Biopharmaceutical firm reports net loss of $0.67 per share.

2004 AUG 9 - (NewsRx.com & NewsRx.net) -- Arena Pharmaceuticals, Inc., (ARNA) reported financial results for the second quarter and 6 months ended June 30, 2004.

Total revenues in the second quarter of 2004 were $1.4 million, compared to $3.0 million in the second quarter of 2003. Total revenues for the 6 months ended June 30, 2004, were $7.2 million, compared to $8.3 million for the 6 months ended June 30, 2003.

Arena reported a net loss allocable to common stockholders for the second quarter and the first 6 months of 2004 of $17.0 million, or $0.67 per share, and $29.5 million, or $1.17 per share, respectively. This compares with a net loss allocable to …

No comments:

Post a Comment